BB Biotech AGXSWX:BION +2.14%33 Dividend Yield % is 4.81% as of Jun. 26, 2026, which is 3% below its 10-year median of 4.97. GuruFocus rates XSWX:BION with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 151 Biotechnology companies, BB Biotech AG ranks better than 82.12% on this metric.
As of today (2026-06-26), the Trailing Annual Dividend Yield of BB Biotech AG is 4.81%.
The historical rank and industry rank for BB Biotech AG's Dividend Yield % or its related term are showing as below:
XSWX:BION'
s Dividend Yield % Range Over the Past 10 Years
Min: 3.64 Med: 4.97 Max: 7.88
Current: 4.81
During the past 13 years, the highest Dividend Yield of BB Biotech AG was 7.88%. The lowest was 3.64%. And the median was 4.97%.
XSWX:BION's Dividend Yield % is ranked better than 82.12% of 151
companies
in the Biotechnology industry
Industry Median: 1.5
vs XSWX:BION: 4.81
During the past 12 months, BB Biotech AG's average Dividends Per Share Growth Rate was 25.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -22.40% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -13.90% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -2.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of BB Biotech AG was 52.60% per year. The lowest was -27.90% per year. And the median was 6.70% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
BB Biotech AG (XSWX:BION) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for BB Biotech AG's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:BION vs VRTX, REGN, ALNY: Dividend Yield % Comparison
For the Biotechnology subindustry, BB Biotech AG's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BB Biotech AG Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BB Biotech AG's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where BB Biotech AG's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
BB Biotech AG Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CHF 2.250000
2026-03-23
2026-03-24
2026-03-25
Cash Dividend
annually
CHF:CHF 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
BB Biotech AG's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
2.25
/
47.80
=
4.71 %
Current Share Price is CHF47.80. BB Biotech AG's Dividends per Share for the trailing twelve months (TTM) ended in Today is CHF2.25.
BB Biotech AG's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
2.25
/
47.80
=
4.71 %
Current Share Price is CHF47.80. BB Biotech AG's Dividends per Share for the forward twelve months is calculated as CHF2.25 * 1 = CHF2.25.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BB Biotech AG (XSWX:BION) has a Dividend Yield % of 4.81% as of Jun. 26, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on BB Biotech AG and its competitors. This is near median its historical median of 4.97. Over the past decade, BB Biotech AG's Dividend Yield % has ranged from 3.64 to 7.88. According to the industry distribution chart, BB Biotech AG ranks #27 out of 151 companies in the Biotechnology industry, placing it in the top 17.9%.
Is BB Biotech AG's Dividend Yield % too high?
BB Biotech AG's current Dividend Yield % of 4.81% is near median its 10-year median of 4.97. Over the past 10 years, this metric has ranged from a low of 3.64 to a high of 7.88. The Biotechnology industry median Dividend Yield % is 1.50. BB Biotech AG's value of 4.81% is 220.7% above this industry median. Based on the distribution chart, BB Biotech AG ranks #27 out of 151 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, BB Biotech AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #27 out of 151 companies for Dividend Yield %. This places BB Biotech AG in the top 18% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 1.50. BB Biotech AG's value of 4.81% is 220.7% above this benchmark. Historically, BB Biotech AG's own Dividend Yield % has ranged from 3.64 to 7.88 over the past decade. While the company's 10-year median is 4.97 vs. the industry median of 1.50, BB Biotech AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.50, based on 151 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BB Biotech AG's current Dividend Yield % of 4.81% is 220.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on BB Biotech AG and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BB Biotech AG's current Dividend Yield % is 4.81%, which is near median its own 10-year median of 4.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current Dividend Yield % of 4.81%. The current Dividend Yield % is 4.81%, which is near median its 10-year median of 4.97 and 220.7% above the Biotechnology industry median of 1.50. BB Biotech AG's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current Dividend Yield % is 4.81% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
33GF Score
Get the complete analysis for XSWX:BION
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:BION has been successfully added to your 
